Angiotensin Receptor 1 Blockers Prolong Time to Recurrence after Radiofrequency Ablation in Hepatocellular Carcinoma patients: A Retrospective Study
Inhibition of angiotensin II synthesis seems to decrease hepatocellular carcinoma recurrence after radical therapies; however, data on the adjuvant role of angiotensin II receptor 1 blockers (sartans) are still lacking. Aim of the study was to evaluate whether sartans delay time to recurrence and pr...
Main Authors: | Antonio Facciorusso, Mohamed A. Abd El Aziz, Ivan Cincione, Ugo Vittorio Cea, Alessandro Germini, Stefano Granieri, Christian Cotsoglou, Rodolfo Sacco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/10/399 |
Similar Items
-
Prolonged post-ablation fever may predict one-year tumor recurrence in hepatocellular carcinoma after radiofrequency ablation
by: Ping-Hung Ho, et al.
Published: (2020-01-01) -
The short-term efficacy of no-touch radiofrequency ablation in treating cirrhosis-based small hepatocellular carcinoma
by: Yuelong Chai, et al.
Published: (2019-05-01) -
Changes of immune cells in patients with hepatocellular carcinoma treated by radiofrequency ablation and hepatectomy, a pilot study
by: Yu Zusheng, et al.
Published: (2021-09-01) -
Complications after Thermal Ablation of Hepatocellular Carcinoma and Liver Metastases: Imaging Findings
by: Federica De Muzio, et al.
Published: (2022-05-01) -
A systematic review and meta-analysis of the comparison of laparoscopic radiofrequency ablation to percutaneous radiofrequency ablation for hepatocellular carcinoma
by: Ya-Qiong Wang, et al.
Published: (2025-03-01)